Tap the Weight-Loss Drug Market With These ETFs Zacks Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs. Business Eli Lilly (LLY) 1 day
Small Business Owners Lose an Average of 7 Hours of Sleep Per Week — Here’s What’s Causing It Entrepreneur 3 hours
Tesla China On Pace For Best Quarter Ever. Will It Be Enough To Boost The EV Giant’s Auto Segment? Investor's Business Daily 4 hours
Business travel is back—and getting better. Here’s how to make your next work trip feel like leisure Fast Company 5 hours
Ad exec listed his divorce on LinkedIn—he says it taught him patience and anger management Fortune 5 hours
Billionaire tech CEO says bosses shouldn’t ‘BS’ employees about the impact AI will have on jobs CNBC 11 hours
Mark Cuban wants to take out Chinese knockoffs, and he says Kamala Harris is on the same page Business Insider 13 hours
Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In Insider Monkey 18 hours
QUALCOMM Incorporated (QCOM) Explores The Possibility Of Buying The Chip Design Business Of Intel In A Bid To Improve The AI Product Line Insider Monkey 19 hours
Exclusive-Google offered to sell part of ad tech business, not enough for EU publishers, sources say Investing.com 23 hours
Intel’s Foundry Finally Has Some Good News. Has the Chipmaker Learned Its Lesson? The Motley Fool 23 hours
At 24, She Was Fired From Her Advertising Job. Then an ‘Incredibly Important’ Mindset Helped Her Build a Multimillion-Dollar Business. Entrepreneur 23 hours
If You Bought 1 Share of Micron Technology at Its IPO, Here’s How Many Shares You Would Own Now The Motley Fool 1 day
This $1,400 luggage is the hottest quiet status symbol for celebrities and wealthy travelers. The more beat up it looks, the better. Business Insider 1 day
TNW Podcast: The business of flight tracking, the new Commission, and some pet tech The Next Web 1 day
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly’s Weight-Loss Treatments The Motley Fool 1 day
This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk’s and Eli Lilly’s Weight Loss Treatments The Motley Fool 1 day